In search of a Kuur: Cell Medica rebrands and regroups, taking a new name, a new CEO and new money
Four years after London-based upstart Cell Medica teamed up with Baylor to work on next-gen cell therapies, the company is doing a complete makeover and adding some new cash to the reserves.
Out goes the name. Cell Medica is now Kuur Therapeutics, which is looking to launch a new Phase I study, matching the first one in the clinic, using their chimeric antigen receptor natural killer T cell (CAR-NKT) therapy platform. Kuur is based in Houston, close to its partners at Baylor.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.